Loading
AP
Aeolus Pharmaceuticals, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by McManus John L, was filed 06 Mar 2013.
Aeolus Pharmaceuticals, Inc.: what insiders have been doing
Aeolus Pharmaceuticals, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). The past year has been quiet: not a single insider filing for Aeolus Pharmaceuticals, Inc. The previous disclosure was published on 30 December 2016.
Over the whole record (from 2006), the tally stands at 125 purchases and 7 sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
192
Thresholds
n/a
Buy Volume
€3M
125 ops. · all time
Sell Volume
€2M
7 ops. · all time
Since the insiders bought
- -28.0%Entry 0.38 · Close at T+365 0.27
- +66.6%Entry 0.24 · Close at T+365 0.40
- +33.3%Entry 0.30 · Close at T+365 0.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 30 December 2016
Declarations192 total
25,000 shares@ US$0.15100.0% of flowCommon StockSEC:0001102624-16-003743:0
10,000 shares@ US$0.35Common StockSEC:0001102624-13-000291:0
Canonical exit: 4 Jun 2013 (T+90)
59,149,999 sharesCommon Stock, $0.01 par value per shareSEC:0001140361-13-008801:0
1,793,894 shares@ US$0.33Common Stock, $0.01 par value per shareSEC:0001140361-13-008801:1
400,000 sharesCommon Stock, $0.01 par value per shareSEC:0001102624-13-000218:0
Canonical exit: 20 May 2013 (T+90)
7,027 shares@ US$0.2388Common StockSEC:0001102624-12-000460:0
Canonical exit: 21 Aug 2012 (T+90)
333,333 shares@ US$0.30Common Stock, $0.01 par value per shareSEC:0001102624-12-000285:0
Canonical exit: 4 Jul 2012 (T+90)
10,000 shares@ US$0.45Common StockSEC:0001144204-11-032225:0
Canonical exit: 22 Aug 2011 (T+90)
300 shares@ US$0.47Common StockSEC:0001144204-11-032225:1
Canonical exit: 22 Aug 2011 (T+90)
10,000 shares@ US$0.43Common StockSEC:0001144204-11-031190:0
Canonical exit: 16 Aug 2011 (T+90)
5,000 shares@ US$0.41Common StockSEC:0001144204-11-031187:0
Canonical exit: 16 Aug 2011 (T+90)
5,000 shares@ US$0.42Common StockSEC:0001144204-11-031187:1
Canonical exit: 16 Aug 2011 (T+90)
193,234 shares@ US$0.76Common StockSEC:0001140361-11-017510:0
3,799,380 shares@ US$0.61Common StockSEC:0001140361-11-017510:1
10,000 shares@ US$0.7414Common StockSEC:0001144204-11-014883:0
Canonical exit: 13 Jun 2011 (T+90)
2,500,000 shares0Common Stock, $0.01 par value per shareSEC:0001140361-11-010942:0
882,488 shares0Common Stock, $0.01 par value per shareSEC:0001140361-11-010946:0
882,488 shares0Common Stock, $0.01 par value per shareSEC:0001140361-11-010944:0
2,500,000 shares0Common Stock, $0.01 par value per shareSEC:0001140361-11-010940:0
7,000 shares@ US$0.95Common StockSEC:0001140361-11-010589:0
57,600 shares@ US$0.97Common StockSEC:0001140361-11-010589:1
616,450 shares0Common StockSEC:0001140361-11-007750:0
776,904 shares0Common StockSEC:0001140361-11-007750:1
2,500,000 sharesCommon Stock, par value $0.01 per shareSEC:0001144204-10-044301:0
Canonical exit: 9 Nov 2010 (T+90)
2,500,000 sharesCommon Stock, par value $0.01 per shareSEC:0001144204-10-044309:0
Canonical exit: 9 Nov 2010 (T+90)
25 of 192 declarations
About Aeolus Pharmaceuticals, Inc.
Aeolus Pharmaceuticals, Inc. is a company focused on developing treatments for respiratory diseases. It is listed on NASDAQ under the symbol AEOL.
